Enabling AI to Drive Innovation and Precision across Oncology R&D.
Saved in:
| Title: | Enabling AI to Drive Innovation and Precision across Oncology R&D. |
|---|---|
| Authors: | Goodwin RJA; Predictive AI & Data, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca (United Kingdom), Cambridge, United Kingdom., Barry ST; Bioscience, Early Oncology R&D, AstraZeneca (United Kingdom), Cambridge, United Kingdom., Weatherall J; Enterprise Data Enablement, Enterprise AI Unit, AstraZeneca (United Kingdom), Macclesfield, United Kingdom., Platz SJ; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca (United Kingdom), Cambridge, United Kingdom., Reis-Filho JS; AI for Science Innovation, Enterprise AI Unit, AstraZeneca (United States), Gaithersburg, Maryland. |
| Source: | Cancer discovery [Cancer Discov] 2026 May 01; Vol. 16 (5), pp. 847-851. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2159-8290 |
|---|---|
| DOI: | 10.1158/2159-8290.CD-26-0271 |
